NCT06573294
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06573294
Title Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genmab
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229 United States Details
National Cancer Center, Tsukiji 5-1-1 Tokyo Japan Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Start Madrid Centro Integral Oncologico Clara Campal CIOCC Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field